Trulieve Cannabis (TRLV) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is TRLV's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

New Hillsborough County location will host grand opening celebration Friday, November 20 TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and …

TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company is …

TALLAHASSEE, Fla., Nov. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event partic…

Trulieve Cannabis (NYSE: TRLV) reported third-quarter revenue of $230 million, up 4% from both a year earlier and the prior quarter on a medical-only basis, as growth in Georgia and Pennsylvania helped the cannabis opera…

New Trulieve-branded kiosk offers qualified patients product access, education, and personalized guidance TALLAHASSEE, Fla., Nov. 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company…

Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript…

Third quarter revenue of $230 million, with 64% gross margin Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 Received final DEA registrations pursuant to final o…

TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has rec…

On October 23, 2026, Trulieve Cannabis Corp (TRLV) shares fell 4.6%, currently priced at $10.42. This move comes amid a 52-week range of $4.62 to $13.28, indica…

Trulieve Cannabis (NYSE: TRLV - Get Free Report) and Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based…

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.…

TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the full repayment of…

TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV ) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thurs…

Trulieve Cannabis Corp. (NYSE: TRLV - Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $12.41, but opened at $10.86. Trulieve Cannabis shares last traded at $10.7260, …

I reiterate my Buy rating on AdvisorShares Pure US Cannabis ETF despite the DEA pausing rescheduling hearings. MSOS remains attractive as the rescheduling catalyst is delayed, not canceled, and underlying holdings appear…

Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing med…

Trulieve Cannabis Corp. (NYSE: TRLV - Get Free Report) saw a significant growth in short interest in September. As of September 15th, there was short interest totaling 5,117,058 shares, a growth of 254.2% from the August…

On September 22, 2026, Trulieve Cannabis Corp (TRLV) shares rose 8.4%, currently priced at $12.47. The stock's price has fluctuated between a 52-week low of $4.…

Inclusion Marks Another Milestone as Trulieve Broadens U.S. Capital Markets Exposure TALLAHASSEE, Fla., Sept. 22, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top…

Trulieve Cannabis Corp. is reinitiated as a Buy, driven by regulatory catalysts and attractive valuation after a recent 81% rally. Rescheduling of medicinal cannabis to Schedule III eliminates punitive tax burdens, boost…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.

